Pharmafile - Medical Communications News
In the last week, a number of new developments have made the news; for COVID-19, the Oxford-AstraZeneca vaccine has been suspended in 11 European...
The Russian Direct Investment Fund (RDIF) and Stelis Biopharma have today announced a partnership which aims to produce and supply a minimum of 200...
A new second line triple therapy is to be offered to NHS patients in England with multiple myeloma, following a NICE recommendation announced today.
AstraZeneca’s COVID-19 vaccine has been cleared for continued use by the EMA following an investigation into the reports of 37 thromboembolic events...
A new precision drug combination, olaparib with bevacizumab, will now be available on the Cancer Drugs Fund (CDF) for ovarian cancer treatment...
In the last week, a number of new treatment developments have made the news; for COVID-19, GSK and Vir’s monoclonal-antibody drug has been found to...
Kintor Pharmaceutical’s Proxalutamide treatment has been proven to reduce risk of mortality from COVID-19 by 92%, in a clinical trial conducted on...
The European Commission has granted Johnson and Johnson’s single-shot COVID-19 vaccine Conditional Marketing Authorisation (CMA), it was announced...
Novavax has announced final efficacy of 96.4% against mild, moderate, and severe disease caused by the original COVID-19 strain in a pivotal UK...
Altimmune has expanded its previously-announced AdCOVID vaccine manufacturing collaboration with Lonza.